Arizona State University (ASU)

ASU Launches Comprehensive Summer School 2020 Program for Learners at all Levels

27-Apr-2020 10:00 AM EDT, by Arizona State University (ASU)

Newswise — (Tempe, Ariz.)  - What does Summer School look like for students in 2020? In a period of economic uncertainty with shifting job markets and employment opportunities that are evaporating in some places and springing to life in others, higher education remains one of the best investments people can make. And for those who find themselves thrust into a new set of circumstances by changes brought on by the coronavirus pandemic, universities offer a dynamic place to explore options and quench the thirst for learning something new. 

To meet the demand for Summer School 2020, beginning May 18 Arizona State University will be offering more than 5,000 courses at a reduced rate to people looking for new learning opportunities and for students at all levels – including students who are currently enrolled in good standing at any university in the United States. Application fees for college students enrolled at other universities will be waived, and scholarships are available for most admitted and currently enrolled ASU students.

Named by U.S. News & World Report as the most innovative university in America for five consecutive years, ASU is stepping up to meet the needs of learners who want to keep pace, get ahead or catch up in the distance learning environment that now defines education in America. Classes will be provided in both the traditional online format and in a fully interactive, digitally-enhanced format for:  

  • Learners at all stages can learn through ASU for You, most of which is free, and can take a course in a subject matter of interest with ASU Open Scale, with the option to convert it to university credit if they later choose to do so.
  • Any university student in the U.S. in good standing at their home college or university may enroll in summer courses through a streamlined application process that takes 15 minutes with approval within 48 hours.
  • Admitted ASU students who wish to get started right now on their university education will receive a $500 Summer 2020 Award for every three credit hours enrolled.  
  • High school sophomores and juniors who are on track for college and want to begin earning college credit through ASU Digital Prep as well as ASU Open Scale classes.
  • Continuing ASU students will continue to have access to all ASU summer courses. Financial aid and scholarships will be available.

ASU has also transferred other services for students to a digital environment to ensure continuity of all aspects of the university experience during COVID-19 and during Summer School 2020. For example, ASU’s Career and Professional Development Services is fully virtual, offering drop-in career and internship advising. ASU Counseling Services have moved entirely online and a peer-led Zoom support group has been created, Devils 4 Devils Support Circles, for students to support and connect with each other while taking classes online and practicing social distancing. Many student events and programs have also transitioned to a virtual format, with a wide variety of activities and events still available.

For convenience and to meet varying schedules, ASU will be providing more than 20 of its most popular, sought-after classes in a rolling rotation of new summer semesters offered with multiple start dates, beginning May 18. For more information, please visit: https://summer2020.asu.edu.

 

About Arizona State University Arizona State University has developed a new model for the American Research University, creating an institution that is committed to access, excellence and impact. ASU measures itself by those it includes, not by those it excludes. As the prototype for a New American University, ASU pursues research that contributes to the public good, and ASU assumes major responsibility for the economic, social and cultural vitality of the communities that surround it.




Filters close

Showing results

110 of 5584
Released: 7-May-2021 1:40 PM EDT
There is no evidence that vaccines could cause harm to people who have recovered from COVID-19
Newswise

An article published by Robert F. Kennedy Jr.’s anti-vaccination organization and widely shared on social media questions the need of vaccinating those who’ve already recovered from COVID-19. The article says there’s a "potential risk of harm, including death" in getting the vaccines. We report this claim as false. There is no evidence that vaccinating people who had previously had COVID is resulting in an increased risk of adverse events.

Newswise: Abbott.jpg
Released: 7-May-2021 1:00 PM EDT
FSU expert available to discuss intellectual property and COVID-19 vaccines
Florida State University

By: Bill Wellock | Published: May 7, 2021 | 11:55 am | SHARE: President Joe Biden has expressed his support for a World Trade Organization proposal to waive intellectual property rights for COVID-19 vaccines.Florida State University law professor Frederick Abbott, the Edward Ball Eminent Scholar Professor of International Law, is available to comment on international intellectual property rights and global economic issues around the proposal.

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-May-2021 11:15 AM EDT
Asthma attacks plummeted among Black and hispanic/latinx individuals during the COVID-19 pandemic
Brigham and Women’s Hospital

Asthma attacks account for almost 50 percent of the cost of asthma care which totals $80 billion each year in the United States

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 10:40 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-May-2021 9:00 AM EDT
Navigating the COVID-19 crisis to prevent pressure injuries: Learning health system helped one hospital adapt and update care in real time
Wolters Kluwer Health: Lippincott

Early in the COVID-19 pandemic, healthcare systems scrambled to modify patient care processes – particularly when it came to strategies aimed at reducing the risk of hospital-related complications. A look at how one hospital applied its learning health system (LHS) framework to respond to a COVID-19-related increase in hospital-acquired pressure injuries (HAPIs) is presented in the May/June Journal for Healthcare Quality (JHQ), the peer-reviewed journal of the National Association for Healthcare Quality (NAHQ). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Ultra-Fast COVID-19 Sensor Invented at Texas Tech Gets Boost Into International Markets
Released: 7-May-2021 8:55 AM EDT
Ultra-Fast COVID-19 Sensor Invented at Texas Tech Gets Boost Into International Markets
Texas Tech University

EviroTech LLC announced today (May 7) a $4 million investment into the company by 1701 Ventures GmbH of Göttingen, Germany, which will allow EviroTech to complete the final design, production startup and market introduction of its Ultra-Fast COVID-19 detection sensor.

Released: 7-May-2021 7:05 AM EDT
Rutgers Recruiting Participants for Pfizer COVID-19 Pediatric Vaccine Clinical Trial
Rutgers University-New Brunswick

Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children ages 6 months to 11 years. This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.


Showing results

110 of 5584

close
2.02211